Antidepressant Response Associated With Pioglitazone: Support for an Overlapping Pathophysiology Between Major Depression and Metabolic Syndrome

Similar Items

• Use of Insulin Sensitizers for the Treatment of Major Depressive Disorder: A Pilot Study of Pioglitazone for Major Depression Accompanied by Abdominal Obesity
  od: Kemp, David E., i dr.
  Izdano: (2011)
• Depressive Symptoms and Diabetes
  od: Kemp, David E., i dr.
  Izdano: (2008)
• PPAR-γ Agonism as a Modulator of Mood: Proof-of-Concept for Pioglitazone in Bipolar Depression
  od: Kemp, David E., i dr.
  Izdano: (2014)
• The Roles of BDNF in the Pathophysiology of Major Depression and in Antidepressant Treatment
  od: Lee, Bun-Hee, i dr.
  Izdano: (2010)
• Glutamate and GABA Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine
  od: Lener, Marc S., i dr.
  Izdano: (2016)